ArticleReproduction & fertility2026
Fertilization time and oocyte spindle integrity: implication for embryo ploidy.
Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
graphical abstractABSTRACT: The aim of this retrospective study in assisted reproductive technology was to provide new evidence that i) the visibility of the meiotic spindle (MS) in human oocytes with an extruded first polar body predicts not only nuclear maturation but also embryo ploidy and ii) the interval between ovulation triggering and ICSI-mediated fertilization affects the chromosomal status of embryos. MS visibility was assessed using polarized light microscopy, and the trigger-to-fertilization interval was adjusted accordingly to increase the likelihood of complete oocyte nuclear maturation. Extending the trigger-fertilization interval based on MS status significantly increased the proportion of mature oocytes (displaying both MS and polar body) from 79 to 92% (P < 0.05), indicating ongoing spindle assembly. Of 1,879 oocytes examined under polarized light, 462 (24.5%) developed into embryos undergoing PGT-A. Embryos derived from immature oocytes (without visible MS or with a spindle bridge to the polar body) had a euploidy rate of 14%, compared with 42% in embryos from mature (visible MS) oocytes (P < 0.05). Differences in embryo euploidy were also associated with the interval between ovulation trigger and ICSI fertilization. Cycles with a trigger-ICSI interval of 40-44 h had a significantly higher likelihood of euploidy (47%) compared with cycles in which the trigger-ICSI interval was 36-39 h (33%) (P < 0.05). For example, in women of advanced maternal age, who exhibit an increased risk of embryonic aneuploidy, spindle-guided assessment of oocyte maturation and quality may improve the prediction of subsequent embryo ploidy. LAY SUMMARY: This IVF study investigated whether giving human eggs more time to mature before fertilization can improve embryo quality. Eggs showing clear signs of full maturity under the polarization microscope were more likely to develop into embryos with the correct number of chromosomes. Having the correct chromosome number is important for healthy embryo development and a successful pregnancy. Eggs that were given a few extra hours to mature before fertilization were more likely to produce healthy embryos with the correct number of chromosomes. The best results were seen when fertilization took place 40-44 h after the hormone injection, rather than 36-39 h later. Fertilization was carried out using a procedure in which a single sperm is injected directly into an egg. These findings suggest that careful assessment of egg maturity and optimization of fertilization timing may help improve IVF outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.